Elderly Breast Cancer Patients Less Likely To Get Surgery, UK
6/16/2011

Older women in the UK are less likely to have surgery for breast cancer than younger ones. And this difference can't be fully explained by age-related ill health from other diseases, according to new data presented today at the National Cancer Intelligence Network (NCIN) conference (Thursday)...

Vaccine Study Supports Immune Targeting Of Brain Tumors
6/16/2011

An experimental vaccine developed by researchers at Cedars-Sinai Medical Center's Maxine Dunitz Neurosurgical Institute targets overactive antigens in highly aggressive brain tumors and improves length of survival in newly diagnosed patients, according to new data that was presented in a poster session at the 47th Annual Meeting of the American Society of Clinical Oncology...

Phase 2 Data On Provectus's PV-10 For Metastatic Melanoma To Be Presented At Two Upcoming Conferences
6/16/2011

Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, announces that data from its Phase 2 PV-10 metastatic melanoma study will be presented at two upcoming melanoma conferences. On June 21, 2011, Dr. Sanjiv Agarwala, Chief of Medical Oncology and Hematology at St...

Seattle Genetics To Present Brentuximab Vedotin And Dacetuzumab Clinical Data At International Conference On Malignant Lymphoma
6/16/2011

Seattle Genetics, Inc. (Nasdaq:SGEN) today announced that data from its brentuximab vedotin (ADCETRIS™) and dacetuzumab (SGN-40) programs will be presented at the 11th International Conference on Malignant Lymphoma (ICML) being held June 15-18, 2011 in Lugano, Switzerland...

COMPLETE Registry Provides First Glance Into Treatment Patterns For Patients With Peripheral T-Cell Lymphoma
6/16/2011

Allos Therapeutics, Inc. (NASDAQ: ALTH) today announced the presentation of initial data from COMPLETE, an international registry designed to address the urgent need for an increased understanding of the treatment patterns and outcomes for patients with peripheral T-cell lymphoma (PTCL). The registry, supported by Allos Therapeutics, Inc...

Roadmap Of Estrogen Signaling In Breast Cancer Published
6/16/2011

The first roadmap to mathematical modeling of a powerful basic "decision circuit" in breast cancer has been developed and published in Nature Reviews Cancer. The preliminary mathematical model is the first result of a $7...

Weight At 18 Linked To Cancer In Men Decades Later, UK
6/16/2011

Public health researchers, based at the MRC/CSO Social and Public Health Sciences Unit, have identified a link between men being overweight or obese at age 18 and death from cancer in later life. The study shows the link is apparent even if they reduce their weight during middle age...

Altering Messenger RNA Holds Promise For Treating Cystic Fibrosis, Muscular Dystrophy, Cancer
6/16/2011

In a new study published in the journal Nature, scientists discovered an entirely new way to change the genetic code. The findings, though early, are significant because they may ultimately help researchers alter the course of devastating genetic disorders, such as cystic fibrosis, muscular dystrophy and many forms of cancer...

FDA New Sunscreen Rules: What You Can Do In The Meantime
6/16/2011

The U.S. Food and Drug Administration (FDA) is finally making changes to how sunscreens are marketed in the United States as part of the Agency's ongoing efforts to ensure that sunscreens meet modern day standards for safety and effectiveness, while helping consumers have the information they need so they can choose the right sun protection for themselves and their families...

Researchers Find Genetic Changes In Majority Of Advanced Lung Cancers
6/16/2011

Some lung-cancer patients at UT Southwestern Medical Center are responding well to potential new drug therapies targeting genetic mutations. Their participation in a national study is helping to forge new avenues to attack the disease. "For those people who have mutations, a drug that could target this cancer-specific vulnerability should be very impactful," said Dr...